Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Forward Pharma A/S is a Danish biopharmaceutical company that developed a proprietary DMF formulation for inflammatory and neurological conditions from 2005 to 2017. In 2017, it licensed its IP to Biogen for $1.25 billion, returned EUR 917.7 million to shareholders, and plans to enter solvent liquidation in 2025.

List your booth number for exhibitions, ask us